Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoporosis, Postmenopausal

In brief

The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.

Key facts

Study ID

NCT00046137

Run by

Eli Lilly and Company

Last updated by the study team

2006-07-20

Who can join

Age: 45 and older, up to 85. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Must be diagnosed with osteoporosis.
• Must be female, age 45 through 85.
• Must be at least 5 years postmenopausal.
• Must be free of other severe or chronically disabling conditions.
• Must be able to properly use injection device.

You may not qualify if…

• Must not have bone diseases other than osteoporosis.
• Must not have history of certain cancers.
• Must not have certain medical diseases (inflammatory bowel disease, malabsorption syndrome, kidney or bladder stones, venous thrombi or emboli, recent vaginal bleeding due to unknown causes).
• Must not have taken or are currently taking certain types of medicines.
• Must not have known allergy to the study agent or SERM.

Where it is running

• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Anaheim, California, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Oakland, California, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Altamonte Springs, Florida, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Chicago, Illinois, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Cedar Rapids, Iowa, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Baltimore, Maryland, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Hagerstown, Maryland, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Voorhees Township, New Jersey, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Cleveland, Ohio, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Oklahoma City, Oklahoma, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Portland, Oregon, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Duncansville, Pennsylvania, United States
• "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician". — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.